Featured Research

from universities, journals, and other organizations

Alzheimer's Pathology Reduced, Longevity Improved In Mouse Model, Study Shows

Date:
May 20, 2004
Source:
University Of California - San Francisco
Summary:
Removal of an enzyme that regulates the activity of many proteins can suppress key features of Alzheimer's disease in experimental models, researchers at the Gladstone Institute of Neurological Disease (GIND) recently reported in the Journal of Neuroscience.

Removal of an enzyme that regulates the activity of many proteins can suppress key features of Alzheimer's disease in experimental models, researchers at the Gladstone Institute of Neurological Disease (GIND) recently reported in the Journal of Neuroscience (May 12, 2004).

Related Articles


Using well-established mouse models of Alzheimer's disease, the investigators examined how changing levels of the enzyme Fyn affects key aspects of the disease, including accumulation of large clumps of amyloid proteins in the brain (so-called plaques) and changes in the complex neuronal networks in which memories are formed and stored. Genetic engineering strategies were used to increase or decrease the expression of Fyn, which regulates many other proteins through the attachment of specific groups of atoms known as phosphate groups.

The researchers determined that changing levels of Fyn had no effect on plaque formation or aberrant sprouting (the abnormal growth of nerve terminals, in which neuchemical messages are stored), indicating that these pathologies involve discrete molecular mechanisms. However, they observed that blocking Fyn expression prevented amyloid proteins from damaging synapses, the specialized connections between brain cells, and improved the longevity of mice. (Experimental mice with Alzheimer's-like disease otherwise die prematurely.) In contrast, increasing Fyn in the brain worsened synaptic damage, and also increased the number of premature deaths in the mice.

Loss of synapses and abnormal outgrowth of nerve terminals occur both in people with Alzheimer's disease and in transgenic mice producing human amyloid proteins in the brain (the model used in the study). Humans with the disease, like mice, die prematurely.

"Synaptic degeneration in Alzheimer's disease is like electrical circuits in a computer becoming faulty -- signals can no longer be transmitted through broken connections," says senior author and GIND director Lennart Mucke, MD, who is also Joseph B. Martin Distinguished Professor of Neuroscience at the University of California, San Francisco.

"Our results suggest that Fyn plays a key role in Alzheimer's-related synaptic impairments, and that it can worsen the toxicity of amyloid proteins," says lead author Jeannie Chin, PhD, a GIND postdoctoral fellow. "We are excited about the possibility that pharmacological modulation of Fyn might be of therapeutic benefit in this disease."

Because Fyn is involved in many different processes related to normal neuronal functioning, complete suppression of its activity might have detrimental side effects, says Mucke. Thus, he says, the researchers will be examining whether partial suppression of Fyn is beneficial. They also will be testing the therapeutic potential of manipulating some of the more specific pathways that Fyn regulates.

This work was supported by C. Lester and Audrey Hogan, the National Institutes of Health, the John Douglas French Alzheimer's Foundation, and the Hillblom Center for the Biology of Aging.

The paper, "Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice," was co-authored by Mucke and fellow GIND staff members Jeannie Chin, Jorge J. Palop and Gui-Qiu Yu; Nobuhiko Kojima of the Neuronal Circuit Mechanisms Research Group, RIKEN Brain Science Institute, Japan; and Eliezer Masliah of the Departments of Neurosciences and Pathology, University of California, San Diego.

The Gladstone Institute of Neurological Disease is one of three research institutes of The J. David Gladstone Institutes, a private, nonprofit biomedical research institution affiliated with UCSF. For further information, visit http://www.gladstone.ucsf.edu.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - San Francisco. "Alzheimer's Pathology Reduced, Longevity Improved In Mouse Model, Study Shows." ScienceDaily. ScienceDaily, 20 May 2004. <www.sciencedaily.com/releases/2004/05/040520062506.htm>.
University Of California - San Francisco. (2004, May 20). Alzheimer's Pathology Reduced, Longevity Improved In Mouse Model, Study Shows. ScienceDaily. Retrieved February 28, 2015 from www.sciencedaily.com/releases/2004/05/040520062506.htm
University Of California - San Francisco. "Alzheimer's Pathology Reduced, Longevity Improved In Mouse Model, Study Shows." ScienceDaily. www.sciencedaily.com/releases/2004/05/040520062506.htm (accessed February 28, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Saturday, February 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Foods to Battle Stress

The Best Foods to Battle Stress

Buzz60 (Feb. 26, 2015) If you&apos;re dealing with anxiety, there are a few foods that can help. Krystin Goodwin (@krystingoodwin) has the best foods to tame stress. Video provided by Buzz60
Powered by NewsLook.com
Sleeping Too Much Or Too Little Might Increase Stroke Risk

Sleeping Too Much Or Too Little Might Increase Stroke Risk

Newsy (Feb. 26, 2015) People who sleep more than eight hours per night are 45 percent more likely to have a stroke, according to a University of Cambridge study. Video provided by Newsy
Powered by NewsLook.com
Mayor Says District of Columbia to Go Ahead With Pot Legalization

Mayor Says District of Columbia to Go Ahead With Pot Legalization

Reuters - News Video Online (Feb. 25, 2015) Washington&apos;s mayor says the District of Columbia will move forward with marijuana legalization, despite pushback from Congress. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Marijuana Nowhere Near As Deadly As Alcohol: Study

Marijuana Nowhere Near As Deadly As Alcohol: Study

Newsy (Feb. 25, 2015) A new study says marijuana is about 114 times less deadly than alcohol. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins